These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17679646)

  • 1. New-onset diabetes, antihypertensive treatment, and outcome.
    Verdecchia P; Angeli F; Reboldi G
    Hypertension; 2007 Sep; 50(3):459-60. PubMed ID: 17679646
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population.
    Aksnes TA; Kjeldsen SE; Rostrup M; Omvik P; Hua TA; Julius S
    Hypertension; 2007 Sep; 50(3):467-73. PubMed ID: 17679652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Valsartan Antihypertensive Long-Term Use Evaluation trial: a study in contrasts.
    Sica DA
    Hypertension; 2006 Sep; 48(3):362-3. PubMed ID: 16864742
    [No Abstract]   [Full Text] [Related]  

  • 4. VALUE in hypertension treatment.
    Berk BC; Bisognano JD
    Curr Hypertens Rep; 2004 Dec; 6(6):411-3. PubMed ID: 15527682
    [No Abstract]   [Full Text] [Related]  

  • 5. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
    Prescrire Int; 2011 Mar; 20(114):67. PubMed ID: 21648225
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in effects of valsartan administration on cardiovascular outcomes in hypertensive patients: findings from the Jikei Heart Study.
    Yoshida H; Shimizu M; Ikewaki K; Taniguchi I; Tada N; Yoshimura M; Rosano G; Dahlöf B; Mochizuki S;
    J Hypertens; 2010 Jun; 28(6):1150-7. PubMed ID: 20467269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; Domínguez MJ; Covelo M; Fernández JR; Mojón A; López JE
    Hypertension; 2003 Sep; 42(3):283-90. PubMed ID: 12874091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the KYOTO HEART study: effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events.
    Sawada T; Takahashi T; Yamada H; Dahlöf B; Matsubara H;
    J Hum Hypertens; 2009 Mar; 23(3):188-95. PubMed ID: 18800142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE study.
    Lins R; Coen N; Aerts A; Macdonald K; Brié H; Hermans C; Shen YM; Lee C; Vancayzeele S; Mecum N; Abraham I
    Arch Cardiovasc Dis; 2011 Aug; 104(8-9):428-34. PubMed ID: 21944144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct; 93(42):1748. PubMed ID: 15529964
    [No Abstract]   [Full Text] [Related]  

  • 12. The VALUE trial: a commentary.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J; Müller U
    MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
    [No Abstract]   [Full Text] [Related]  

  • 15. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension therapy. Does AT-1 blocker help love life?].
    MMW Fortschr Med; 2003 Feb; 145(9):57. PubMed ID: 12666537
    [No Abstract]   [Full Text] [Related]  

  • 19. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
    [No Abstract]   [Full Text] [Related]  

  • 20. Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.
    Hollenberg NK; Parving HH; Viberti G; Remuzzi G; Ritter S; Zelenkofske S; Kandra A; Daley WL; Rocha R
    J Hypertens; 2007 Sep; 25(9):1921-6. PubMed ID: 17762658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.